Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05160636 · ClinicalTrials.gov registry record
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
A clinical trial of COVID-19 and Influenza, sponsored by Pfizer.
- Active
- Registry status
- 999
- Enrollment target
- 1
- Study location
NCT05160636 is a study of COVID-19 and Influenza that is active but no longer recruiting, run by Pfizer. The registered enrollment target is 999 participants, below the 55,210-participant average among 203 other COVID-19 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05160636, a study of COVID-19 and Influenza, is active but no longer recruiting, sponsored by Pfizer.
- ACTIVE NOT RECRUITING
- Registry status
- 999 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to understand: * the symptoms of COVID-19 or influenza- health-related outcomes of people with COVID-19 or influenza (influenza only included in updated study analyses) * the potential effects of COVID-19 vaccines in people with COVID-19 This study will enroll participants who are: * 18 years or older * reported to have symptoms with tests that have confirmed illness. The tests can be taken at any of CVS pharmacy COVID-19 or influenza test sites. The study will collect vaccine history information from participants who are ready to take part in the study. Participant will be emailed a form with questions about their health related to COVID-19 or influenza during multiple follow-ups over a 6-month period.
Conditions Studied
Interventions
- BIOLOGICAL COVID-19 Vaccine
Study Locations (1)
New York
- Pfizer - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 999 participants |
| Start Date | 2022-01-31 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05160636
The ClinicalTrials.gov registry entry for NCT05160636 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 999 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,210-participant average among 203 other COVID-19 trials with a reported enrollment target (98% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which COVID-19 Vaccine is the first listed.
NCT05160636 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05160636 about?
NCT05160636 is a clinical study titled "A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza". The main purpose of this study is to understand: * the symptoms of COVID-19 or influenza- health-related outcomes of people with COVID-19 or influenza (influenza only included in updated study analyses) * the potential effects of COVID-19 vaccines in people with COVID-19 This study will enroll par...
What is the current status of trial NCT05160636?
This trial is currently active not recruiting. The enrollment target is 999 participants. The study started on 2022-01-31. Estimated completion is 2026-02-28.
What conditions does trial NCT05160636 study?
This clinical trial studies the following conditions: COVID-19, Influenza, Coronavirus Disease 2019.
What interventions are being tested in trial NCT05160636?
The interventions under investigation include: COVID-19 Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05160636?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05160636 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.